Trial Profile
A 6-week, randomized prospective open-label multi-center study, to compare aripiprazole augmentation versus bupropion combination in patients with major depressive disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Feb 2015
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Bupropion
- Indications Major depressive disorder
- Focus Therapeutic Use
- 07 Feb 2015 New trial record